Back to Quadrature Capital Ltd Quadrature Capital Ltd

IOVAIOVA

6 quarters

Position history for Quadrature Capital LtdQuadrature Capital Ltd's holdings in Iovance Biotherapeutics, Inc.

Yes. Quadrature Capital holds 278,937 shares of IOVA (Iovance Biotherapeutics), worth $1.2M, as of its Q2 2026 13F filing. It increased the position by 120,008 shares (+75.5%) from Q1 2026. Quadrature Capital has held IOVA since Q4 2025, across 3 quarterly 13F filings.

Current Value

$1.2M

Current Shares

278,937

Total Value Change

+$1.1M

Total Shares Change

+246,205

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
278,937
+75.5%
$1.2M0.0%$4.16
38
2026-Q1
Decreased
158,929
-50.1%
$557,8410.0%$3.51
0
2025-Q4
New
318,703
—
$870,0590.0%$2.73
34
2025-Q3
Exited
0
-100.0%
$00.0%$2.17
0
2025-Q2
Increased
144,124
+340.3%
$247,1730.0%$1.72
37
2025-Q1
New
32,732
—
$108,8340.0%$3.33
30

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used